APT Medical Inc. (SHA:688617)

China flag China · Delayed Price · Currency is CNY
230.91
+3.51 (1.54%)
At close: Mar 6, 2026
-9.60%
Market Cap 32.57B
Revenue (ttm) 2.58B
Net Income (ttm) 820.64M
Shares Out 141.03M
EPS (ttm) 5.82
PE Ratio 39.68
Forward PE 29.78
Dividend 1.21 (0.52%)
Ex-Dividend Date Jun 19, 2025
Volume 781,459
Average Volume 1,088,234
Open 227.59
Previous Close 227.40
Day's Range 226.59 - 233.75
52-Week Range 223.48 - 337.20
Beta -0.31
RSI 45.65
Earnings Date Mar 25, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, del... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 2,915
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688617
Full Company Profile

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.

Financial Statements

News

There is no news available yet.